Correlation Between PsyBio Therapeutics and Algernon Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both PsyBio Therapeutics and Algernon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PsyBio Therapeutics and Algernon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PsyBio Therapeutics Corp and Algernon Pharmaceuticals, you can compare the effects of market volatilities on PsyBio Therapeutics and Algernon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PsyBio Therapeutics with a short position of Algernon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of PsyBio Therapeutics and Algernon Pharmaceuticals.
Diversification Opportunities for PsyBio Therapeutics and Algernon Pharmaceuticals
-0.22 | Correlation Coefficient |
Very good diversification
The 3 months correlation between PsyBio and Algernon is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding PsyBio Therapeutics Corp and Algernon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Algernon Pharmaceuticals and PsyBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PsyBio Therapeutics Corp are associated (or correlated) with Algernon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Algernon Pharmaceuticals has no effect on the direction of PsyBio Therapeutics i.e., PsyBio Therapeutics and Algernon Pharmaceuticals go up and down completely randomly.
Pair Corralation between PsyBio Therapeutics and Algernon Pharmaceuticals
Assuming the 90 days horizon PsyBio Therapeutics Corp is expected to generate 5.1 times more return on investment than Algernon Pharmaceuticals. However, PsyBio Therapeutics is 5.1 times more volatile than Algernon Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Algernon Pharmaceuticals is currently generating about 0.01 per unit of risk. If you would invest 3.74 in PsyBio Therapeutics Corp on September 3, 2024 and sell it today you would lose (3.73) from holding PsyBio Therapeutics Corp or give up 99.73% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.8% |
| Values | Daily Returns |
PsyBio Therapeutics Corp vs. Algernon Pharmaceuticals
Performance |
| Timeline |
| PsyBio Therapeutics Corp |
| Algernon Pharmaceuticals |
PsyBio Therapeutics and Algernon Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PsyBio Therapeutics and Algernon Pharmaceuticals
The main advantage of trading using opposite PsyBio Therapeutics and Algernon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PsyBio Therapeutics position performs unexpectedly, Algernon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Algernon Pharmaceuticals will offset losses from the drop in Algernon Pharmaceuticals' long position.| PsyBio Therapeutics vs. Health Sciences Gr | PsyBio Therapeutics vs. Vg Life Sciences | PsyBio Therapeutics vs. MedMira | PsyBio Therapeutics vs. Oxford Cannabinoid Technologies |
| Algernon Pharmaceuticals vs. Cellectis SA | Algernon Pharmaceuticals vs. Biotron Limited | Algernon Pharmaceuticals vs. Resverlogix Corp | Algernon Pharmaceuticals vs. Covalon Technologies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |